Empire Life Investments Inc. Gilead Sciences, Inc. Transaction History

Empire Life Investments Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Aug 03, 2020	SELL	$72.34 - $84.0 $4.3 Million - $5 Million	-59,479 Closed	0 $0
Q1 2020 Apr 23, 2020	SELL	$62.63 - $80.22 $21.6 Million - $27.7 Million	-345,153 Reduced 85.3%	59,479 $4.45 Million
Q4 2019 Jan 21, 2020	BUY	$61.62 - $67.78 $24.9 Million - $27.4 Million	404,632 New	404,632 $26.3 Million
Q3 2017 Nov 14, 2017	SELL	$72.11 - $85.47 $4.68 Million - $5.55 Million	-64,923 Closed	0 $0
Q2 2017 Aug 14, 2017	BUY	N/A	64,923	64,923 $4.6 Million

1,893

1.02B

12M

9.04M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $110B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of Empire Life Investments Inc., based on Form 13F filings with the SEC.

Stay updated on Empire Life Investments Inc. with notifications on news.